Search

Your search keyword '"Le Grand, Roger"' showing total 1,081 results

Search Constraints

Start Over You searched for: Author "Le Grand, Roger" Remove constraint Author: "Le Grand, Roger"
1,081 results on '"Le Grand, Roger"'

Search Results

2. MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates

6. Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques

7. Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2

8. Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells

10. A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens

13. In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting

15. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics

16. Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

19. Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques

20. SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19

22. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates

25. Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates

30. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

32. Non-human primate models of human respiratory infections

34. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection

35. An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism.

36. Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.

37. Multiple Mechanisms of Action of Sulfodyne ® , a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.

38. Optimal Maturation of the SIV-Specific CD8+ T Cell Response after Primary Infection Is Associated with Natural Control of SIV: ANRS SIC Study

39. Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccination

40. Predicting the next pandemic: VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics

41. Animal models for COVID-19

42. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

43. Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

45. SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity

47. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models

49. HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry

50. Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

Catalog

Books, media, physical & digital resources